Equities

Neuland Laboratories Ltd

NEULANDLAB:NSI

Neuland Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)12,723.60
  • Today's Change83.85 / 0.66%
  • Shares traded8.07k
  • 1 Year change+246.22%
  • Beta1.3663
Data delayed at least 15 minutes, as of Sep 20 2024 09:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income4,0142,157822
Depreciation/depletion597528490
Non-Cash items3.81233173
Cash taxes paid, supplemental1,116436205
Cash interest paid, supplemental141132136
Changes in working capital(2003)(546)(881)
Total cash from operations2,6122,372604
INVESTING
Capital expenditures(1437)(661)(977)
Other investing and cash flow items, total(60)4622
Total cash from investing(1497)(615)(955)
FINANCING
Financing cash flow items(141)(132)(136)
Total cash dividends paid(128)(64)(38)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(424)(1162)551
Total cash from financing(693)(1358)377
NET CHANGE IN CASH
Foreign exchange effects(0.49)4.070.62
Net change in cash42240327
Net cash-begin balance/reserved for future use4545124
Net cash-end balance/reserved for future use87645451
SUPPLEMENTAL INCOME
Depreciation, supplemental597528490
Cash interest paid, supplemental141132136
Cash taxes paid, supplemental1,116436205
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.